Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Moderate NMB and Sugammadex in TURB
NCT03039543Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jun 2017
- Primary completion
- Nov 2017
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Seoul National University Bundang Hospital. Started Jun 2017; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03039543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03039543.